調査レポートカテゴリー： MarketsandMarkets, 世界

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024

ゲノミクスの世界市場予測（～2024年）

◆タイトル：Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
◆商品コード：BT-2209
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年3月25日
◆ページ数：195
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

ゲノミクスの世界市場は、2019年の189億米ドルから2024年には357億米ドルに達し、この期間中13.5％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、政府の援助資金の増加、ゲノミクスプロジェクトの増加、シーケンスコストの削減、ゲノミクスの応用分野の拡大、ゲノミクス分野への企業の新規参入などが考えられます。一方で、ゲノム関連機器の高コストは市場の成長を抑制する主な要因です。当調査レポートでは、ゲノミクスの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品・サービス（システム・ソフトウェア、消耗品、サービス）分析、技術（シーケンシング、マイクロアレイ、PCR）分析、用途（診断、精密医療）分析、エンドユーザー（研究所）分析、ゲノミクスの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“Genomics market is projected to grow at a CAGR of 13.5% during the forecast period”The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the genomics market. However, the high cost of genomic equipment is one of the major factors restraining the growth of this market.

“The services segment is projected to grow at the highest CAGR during the forecast period”
Based on product & service, the genomics market is segmented into consumables, systems & software, and services. During the forecast period, the services segment is expected to grow at the highest CAGR majorly due to the increasing awareness of genomics and the reducing cost of DNA sequencing.

“Diagnostic applications to grow at the highest CAGR during the forecast period”
Based on application, the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications. During the forecast period, the diagnostic applications segment is projected to grow at the highest CAGR majorly due to the increasing awareness of genomics among patients and the improving efficiency of genomic sequencing in the diagnosis of diseases.

“In the end-user market, the hospitals and clinics segment is estimated to witness the highest growth during the forecast period”
Based on end user, the genomics market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. During the forecast period, the hospitals and clinics segment is estimated to grow at the highest CAGR owing to the growing availability of genetic tests and pharmacogenomics and the rising emphasis on providing personalized medicine in hospitals.

“Growing investments and favorable government initiatives for genomics research to offer growth opportunities in North America during the forecast period”

During the forecast period, the North American market is estimated to witness high growth owing to factors such as the implementation of favorable initiatives by governments in the US and Canada and rising investments in the pharmaceutical, biotechnology, medical, and academic research sectors in these countries.

Breakdown of supply-side primary interviews:

• By Company Type – Tier I: 55%, Tier II: 25%, and Tier III: 20%
• By Designation – C-level: 43%, Director-level: 32%, and Others: 25%
• By Region – North America: 38%, Europe: 23%, Asia Pacific: 29%, and RoW: 10%

QIAGEN (Netherlands), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies (US), Illumina (US), Pacific Biosciences of California (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (UK), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), and Eppendorf (Germany) are the major players operating in this market.
Research coverage:
This report studies the genomics market based on product and service, application, end user, and region. It also includes an analysis of factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Key benefits of buying the report
This report focuses on various levels of analysis—industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the genomics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 23
2.1.2.1 Key data from primary sources 25
2.1.2.2 Key industry insights 26
2.2 MARKET SIZE ESTIMATION 26
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 28
2.3 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 GENOMICS: MARKET OVERVIEW 35
4.2 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018 36
4.3 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018 37
4.4 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET 38
5 MARKET OVERVIEW 39
5.1 INTRODUCTION 39
5.2 MARKET DYNAMICS 39
5.2.1 DRIVERS 40
5.2.1.1 Rising government funding and growth in the number of genomics projects 40
5.2.1.2 Decreasing sequencing costs 41
5.2.1.3 Growing application areas of genomics 41
5.2.1.4 Entry of new players and start-ups in the genomics market 42
 
5.2.2 RESTRAINTS 42
5.2.2.1 High cost of genomic equipment 42
5.2.3 OPPORTUNITIES 43
5.2.3.1 Use of genomics in specialized/personalized medicine 43
5.2.4 CHALLENGES 43
5.2.4.1 Dearth of trained professionals 43
5.2.4.2 Secure storage of large volumes of sequenced data 44
6 GENOMICS MARKET, BY PRODUCT AND SERVICE 45
6.1 INTRODUCTION 46
6.2 CONSUMABLES 47
6.2.1 CONSUMABLES FORMS THE LARGEST SEGMENT OF THE GENOMICS MARKET 47
6.3 SYSTEMS & SOFTWARE 48
6.3.1 WITH GENOME SEQUENCING AVAILABLE AT SUBSTANTIALLY LOWER RATES, THE DEMAND FOR SYSTEMS & SOFTWARE IS EXPECTED TO INCREASE 48
6.4 SERVICES 51
6.4.1 THE SERVICES SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 51
7 GENOMICS MARKET, BY TECHNOLOGY 53
7.1 INTRODUCTION 54
7.2 PCR 55
7.2.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS 55
7.3 SEQUENCING 56
7.3.1 INCREASING APPLICATIONS OF SEQUENCING IN ANIMAL BREEDING, AGRICULTURE, AND HUMAN GENOMICS TO DRIVE MARKET GROWTH 56
7.4 MICROARRAY 57
7.4.1 MICROARRAY TECHNOLOGIES ARE WIDELY USED IN THE FIELD OF GENOMICS DUE TO THEIR LOW COST 57
7.5 NUCLEIC ACID EXTRACTION AND PURIFICATION 59
7.5.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET 59
7.6 OTHER TECHNOLOGIES 60
8 GENOMICS MARKET, BY APPLICATION 62
8.1 INTRODUCTION 63
8.2 DIAGNOSTICS 64
8.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE GENOMICS MARKET 64
8.3 DRUG DISCOVERY AND DEVELOPMENT 67
8.3.1 GROWING APPLICATION OF GENOMICS IN THE AREA OF DRUG DISCOVERY AND DEVELOPMENT TO PROPEL MARKET GROWTH 67
 
8.4 PRECISION MEDICINE 69
8.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS BASED ON THEIR GENETIC, ENVIRONMENTAL, AND LIFESTYLE FACTORS 69
8.5 AGRICULTURE & ANIMAL RESEARCH 70
8.5.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK 70
8.6 OTHER APPLICATIONS 71
9 GENOMICS MARKET, BY END USER 73
9.1 INTRODUCTION 74
9.2 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 75
9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES 75
9.3 HOSPITALS & CLINICS 77
9.3.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS 77
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 78
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMIC SYSTEMS AND SERVICES AMONG PHARMA & BIOTECH COMPANIES 78
9.5 OTHER END USERS 80
10 GENOMICS MARKET, BY REGION 82
10.1 INTRODUCTION 83
10.2 NORTH AMERICA 85
10.2.1 US 88
10.2.1.1 US dominates the North American genomics market due to the increasing research funding and government initiatives for promoting precision medicine and the use of GM crops 88
10.2.2 CANADA 91
10.2.2.1 Increasing research in the field of genomics to drive market growth 91
10.3 EUROPE 94
10.3.1 UK 96
10.3.1.1 UK to register the highest CAGR in the European genomics market during the forecast period 96
10.3.2 GERMANY 99
10.3.2.1 Availability of funding for life sciences research to boost market growth in Germany 99
10.3.3 FRANCE 101
10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market 101
10.3.4 ROE 103
 
10.4 ASIA PACIFIC 105
10.4.1 CHINA 108
10.4.1.1 China is expected to command the largest share of the Asia Pacific market 108
10.4.2 INDIA 110
10.4.2.1 Emergence of local players is expected to aid the growth of the genomics market in India 110
10.4.3 JAPAN 113
10.4.3.1 Increasing government focus on cancer research in Japan to increase demand for genomics products 113
10.4.4 REST OF ASIA PACIFIC 115
10.5 REST OF THE WORLD 118
10.5.1 MIDDLE EAST AND AFRICA 120
10.5.1.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth 120
10.5.2 LATIN AMERICA 123
10.5.2.1 Government funding and partnerships to boost the adoption of genomics products and services in Latin America 123
11 COMPETITIVE LANDSCAPE 126
11.1 OVERVIEW 126
11.1.1 THERMO FISHER SCIENTIFIC 126
11.1.2 ILLUMINA 127
11.1.3 QIAGEN 127
11.1.4 OTHERS 128
11.2 COMPETITIVE SCENARIO 128
11.2.1 PRODUCT LAUNCHES AND APPROVALS 128
11.2.2 EXPANSIONS 128
11.2.3 AGREEMENTS AND COLLABORATIONS 129
11.2.4 ACQUISITIONS 129
11.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018) 130
11.3.1 VISIONARY LEADERS 130
11.3.2 INNOVATORS 130
11.3.3 DYNAMIC DIFFERENTIATORS 130
11.3.4 EMERGING COMPANIES 130
11.4 COMPETITIVE BENCHMARKING 132
11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES) 132
11.4.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES) 133
 
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018) 134
11.5.1 PROGRESSIVE COMPANIES 134
11.5.2 STARTING BLOCKS 134
11.5.3 DYNAMIC COMPANIES 134
11.5.4 RESPONSIVE COMPANIES 134
12 COMPANY PROFILES 136
(Business Overview, Products Offered, Service Offered Recent Developments, MnM View)*
12.1 ILLUMINA, INC. 136
12.2 THERMO FISHER SCIENTIFIC 143
12.3 QIAGEN 148
12.4 EUROFINS SCIENTIFIC 154
12.5 AGILENT TECHNOLOGIES 157
12.6 OXFORD NANOPORE TECHNOLOGIES 163
12.7 F. HOFFMANN-LA ROCHE 165
12.8 BIO-RAD LABORATORIES 169
12.9 BGI 172
12.10 DANAHER CORPORATION 176
12.11 GE HEALTHCARE 179
12.12 EPPENDORF 183
*Business Overview, Products Offered, Service Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 185
13.1 DISCUSSION GUIDE 185
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 190
13.3 AVAILABLE CUSTOMIZATIONS 192
13.4 RELATED REPORTS 192
13.5 AUTHOR DETAILS 194

LIST OF TABLES

TABLE 1 GENOMICS MARKET, BY PRODUCT AND SERVICE, 2017–2024 (USD MILLION) 46
TABLE 2 GENOMICS MARKET FOR CONSUMABLES, BY COUNTRY,
2017–2024 (USD MILLION) 48
TABLE 3 GENOMICS MARKET FOR SYSTEMS/SOFTWARE, BY COUNTRY,
2017–2024 (USD MILLION) 50
TABLE 4 GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION) 52
TABLE 5 GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 54
TABLE 6 GENOMICS MARKET FOR PCR, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 7 GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 8 GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 9 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION,
BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 10 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2017–2024 (USD MILLION) 61
TABLE 11 GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 64
TABLE 12 GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 13 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT,
BY COUNTRY, 2017–2024 (USD MILLION) 68
TABLE 14 GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY,
2017–2024 (USD MILLION) 69
TABLE 15 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH,
BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 16 GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY,
2017–2024 (USD MILLION) 72
TABLE 17 GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 74
TABLE 18 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 19 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2017–2024 (USD MILLION) 78
TABLE 20 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY COUNTRY, 2017–2024 (USD MILLION) 79
TABLE 21 GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY,
2017–2024 (USD MILLION) 81
TABLE 22 GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION) 84
TABLE 23 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 86
TABLE 24 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 86
TABLE 25 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 86
TABLE 26 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 87
TABLE 27 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 87
TABLE 28 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 89
TABLE 29 US: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 89
TABLE 30 US: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 90
TABLE 31 US: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 90
TABLE 32 INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2018 91
TABLE 33 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 92
TABLE 34 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 92
TABLE 35 0CANADA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 93
TABLE 36 CANADA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 93
TABLE 37 EUROPE: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 95
TABLE 38 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 95
TABLE 39 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 95
TABLE 40 EUROPE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 96
TABLE 41 EUROPE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 96
TABLE 42 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 97
TABLE 43 UK: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 98
TABLE 44 UK: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 98
TABLE 45 UK: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 98
TABLE 46 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 99
TABLE 47 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 100
TABLE 48 GERMANY: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 100
TABLE 49 GERMANY: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 100
TABLE 50 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 101
TABLE 51 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 101
TABLE 52 FRANCE : GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 102
TABLE 53 FRANCE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 102
TABLE 54 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 103
TABLE 55 ROE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 103
TABLE 56 ROE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 104
TABLE 57 ROE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 104
TABLE 58 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 106
TABLE 59 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 106
TABLE 60 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 107
TABLE 61 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 107
TABLE 62 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 107
TABLE 63 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 109
TABLE 64 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 109
TABLE 65 CHINA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 109
TABLE 66 CHINA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 110
TABLE 67 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 111
TABLE 68 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 111
TABLE 69 INDIA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 112
TABLE 70 INDIA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 112
TABLE 71 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 113
TABLE 72 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 114
TABLE 73 JAPAN: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 114
TABLE 74 JAPAN: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 115
TABLE 75 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 116
TABLE 76 ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 116
TABLE 77 ROAPAC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 116
TABLE 78 ROAPAC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 117
TABLE 79 ROW: GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION) 119
TABLE 80 ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 119
TABLE 81 ROW: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION) 119
TABLE 82 ROW: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 120
TABLE 83 ROW: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 120
TABLE 84 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 121
TABLE 85 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 122
TABLE 86 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 122
TABLE 87 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER,
2017–2024 (USD MILLION) 123
TABLE 88 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 124
TABLE 89 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY,
2017–2024 (USD MILLION) 124
TABLE 90 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 124
TABLE 91 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION) 125
TABLE 92 PRODUCT LAUNCHES AND APPROVALS 128
TABLE 93 EXPANSIONS 128
TABLE 94 AGREEMENTS AND COLLABORATIONS 129
TABLE 95 ACQUISITIONS 129


LIST OF FIGURES

FIGURE 1 GENOMICS MARKET SEGMENTATION 18
FIGURE 2 GENOMICS MARKET: RESEARCH METHODOLOGY 20
FIGURE 3 RESEARCH DESIGN 21
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 24
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 28
FIGURE 8 GENOMICS MARKET, BY PRODUCT & SERVICE, 2018 30
FIGURE 9 GENOMICS MARKET, BY TECHNOLOGY, 2018 31
FIGURE 10 GENOMICS MARKET, BY APPLICATION, 2018 32
FIGURE 11 GENOMICS MARKET, BY END USER, 2018 33
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET 34
FIGURE 13 RISING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 35
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN GENOMICS MARKET IN 2018 36
FIGURE 15 CONSUMABLES SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC GENOMICS MARKET IN 2018 37
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 38
FIGURE 17 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019 46
FIGURE 18 PCR SEGMENT WILL CONTINUE TO DOMINATE THE GENOMICS MARKET IN THE FORECAST PERIOD 54
FIGURE 19 DIAGNOSTIC APPLICATIONS TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD 63
FIGURE 20 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019 74
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD 83
FIGURE 22 NORTH AMERICA: GENOMICS MARKET SNAPSHOT 85
FIGURE 23 EUROPE: GENOMICS MARKET SNAPSHOT 94
FIGURE 24 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT 105
FIGURE 25 ROW: GENOMICS MARKET SNAPSHOT 118
FIGURE 26 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018 126
FIGURE 27 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET 131
FIGURE 28 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET 135
FIGURE 29 ILLUMINA, INC.: COMPANY SNAPSHOT (2018) 136
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2017) 143
FIGURE 31 QIAGEN N.V.: COMPANY SNAPSHOT (2017) 148
FIGURE 32 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017) 154
FIGURE 33 AGILENT TECHNOLOGIES : COMPANY SNAPSHOT (2017) 157
FIGURE 34 ROCHE HOLDING AG: COMPANY SNAPSHOT (2017) 165
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017) 169
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 176
FIGURE 37 GENERAL ELECTRICAL COMPANY: COMPANY SNAPSHOT (2017) 179
FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT (2017) 183


★調査レポート[ゲノミクスの世界市場予測（～2024年）] ( Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024 / BT-2209) 販売に関する免責事項
[ゲノミクスの世界市場予測（～2024年）] ( Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024 / BT-2209) についてEメールでお問い合わせ

※関連データはありません。


◆H&Iグローバルリサーチ株式会社のお客様（例）◆